Formidable Asset Management, LLC Bristol Myers Squibb CO Transaction History

Formidable Asset Management, LLC

$609 Million
Q3 2024

A detailed history of Formidable Asset Management, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Formidable Asset Management, LLC holds 10,899 shares of BMY stock, worth $624,839. This represents 0.09% of its overall portfolio holdings.

Number of Shares

10,899

Previous 12,397 12.08%

Holding current value

$624,839

Previous $514,000 9.73%

% of portfolio

0.09%

Previous 0.09%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$39.66 - $51.75 $59,410 - $77,521	-1,498 Reduced 12.08%	10,899 $564,000
Q2 2024 Aug 08, 2024	SELL	$40.25 - $52.99 $41,658 - $54,844	-1,035 Reduced 7.71%	12,397 $514,000
Q1 2024 May 15, 2024	BUY	$47.98 - $54.4 $53,689 - $60,873	1,119 Added 9.09%	13,432 $728,000
Q3 2023 Nov 09, 2023	SELL	$57.89 - $64.73 $17,367 - $19,419	-300 Reduced 2.38%	12,313 $714,000
Q1 2023 May 09, 2023	BUY	$65.71 - $74.53 $6,570 - $7,453	100 Added 0.8%	12,613 $877,000
Q3 2022 Nov 14, 2022	SELL	$0.13 - $76.84 $0 - $537	-7 Reduced 0.06%	12,513 $918,000
Q2 2022 Aug 16, 2022	SELL	$72.62 - $79.98 $937,161 - $1.03 Million	-12,905 Reduced 50.76%	12,520 $946,000
Q1 2022 May 04, 2022	BUY	$61.48 - $73.72 $21,026 - $25,212	342 Added 1.36%	25,425 $1.86 Million
Q4 2021 Feb 07, 2022	BUY	$53.63 - $62.52 $99,376 - $115,849	1,853 Added 7.98%	25,083 $1.56 Million
Q3 2021 Nov 10, 2021	BUY	$59.17 - $69.31 $732,702 - $858,265	12,383 Added 114.16%	23,230 $1.38 Million
Q2 2021 Aug 16, 2021	BUY	$61.91 - $67.42 $655,564 - $713,910	10,589 Added 4104.26%	10,847 $729,000
Q2 2021 Aug 06, 2021	SELL	$61.91 - $67.42 $638,849 - $695,706	-10,319 Reduced 97.56%	258 $558,000
Q1 2021 May 12, 2021	BUY	$59.34 - $66.74 $22,311 - $25,094	376 Added 3.69%	10,577 $667,000
Q4 2020 Jan 29, 2021	SELL	$57.74 - $65.43 $1,385 - $1,570	-24 Reduced 0.23%	10,201 $629,000
Q3 2020 Nov 13, 2020	SELL	$57.43 - $63.64 $5,743 - $6,364	-100 Reduced 0.97%	10,225 $606,000
Q2 2020 Aug 13, 2020	BUY	$54.82 - $64.09 $46,871 - $54,796	855 Added 9.03%	10,325 $609,000
Q4 2019 Feb 13, 2020	BUY	$49.21 - $64.19 $466,018 - $607,879	9,470 New	9,470 $631,000
Q3 2019 Nov 08, 2019	SELL	$42.77 - $50.71 $334,504 - $396,602	-7,821 Closed	0 $0
Q2 2019 Oct 15, 2019	BUY	$44.62 - $49.34 $348,973 - $385,888	7,821 New	7,821 $348,000
Q4 2018 Feb 06, 2019	SELL	$48.76 - $63.23 $593,214 - $769,256	-12,166 Closed	0 $0
Q3 2018 Nov 07, 2018	SELL	$55.19 - $62.25 $95,754 - $108,003	-1,735 Reduced 12.48%	12,166 $762,000
Q2 2018 Aug 08, 2018	BUY	$50.53 - $62.98 $50,428 - $62,854	998 Added 7.73%	13,901 $769,000
Q1 2018 May 04, 2018	SELL	$59.92 - $68.98 $8,568 - $9,864	-143 Reduced 1.1%	12,903 $816,000
Q4 2017 Feb 13, 2018	SELL	$59.94 - $65.35 $2,997 - $3,267	-50 Reduced 0.38%	13,046 $800,000
Q3 2017 Nov 13, 2017	BUY	$55.23 - $63.74 $723,292 - $834,739	13,096	13,096 $835,000

Others Institutions Holding BMY

# of Institutions

2,536

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $122B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Formidable Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Formidable Asset Management, LLC with notifications on news.

Account

Formidable Asset Management, LLC Bristol Myers Squibb CO Transaction History